From Doctors Lounge
2008 - American Diabetic Association - 68th Scientific Sessions
By American Diabetes Association
Jun 7, 2008 - 6:05:29 PM
American Diabetes Association - 68th Annual Meeting was held in San Francisco, June 6 - 10, 2008. The following is a briefing of some of the
articles presented at the conference.
ACCORD clinical trial publishes results
A therapeutic strategy targeting blood sugar to near-normal levels does not reduce cardiovascular events but increases mortality in persons with diabetes at high risk.
ACCORD clinical trial website, http://www.accordtrial.org/public/index.cfm
Weight gain may be healthy when it comes to type 1 diabetes
Gaining body fat may be a good thing, at least for people with type 1 diabetes, say researchers at the University of Pittsburgh Graduate School of Public Health. Their study followed 655 patients with type 1 diabetes for 20 years and found that patients who gained weight over time were less likely to die.
Unique drug combination may hold the key to reversing type 1 diabetes
A team of Virginia scientists led by Jerry L. Nadler, M.D., are reporting promising results from a study that tested a novel therapy for reversing type 1 diabetes. The treatment combines a drug that halts the immune damage that causes type 1 diabetes with another drug that stimulates the pancreas to regenerate.
USC study shows belly fat may affect liver function
A study by the University of Southern California suggests the release of lipids from abdominal fat, which drains directly to the liver, increases overnight, providing additional insight as to how abdominal fat is associated with type 2 diabetes risk.
USC study finds fat mass and obesity assoicated genes increased risk of disease in Mexican-Americans
A study from the University of Southern California suggests people of Mexican-American descent who have genetic variants of fat gene FTO and Arachidonate 5-Lipoxygenase (5-LO) had higher triglyceride and lower HDL levels.
USC study established weight gain as main factor in falling beta cell function in Hispanic women
A study by researchers at the University of Southern California found that weight gain was the strongest factor associated with falling beta cell function in Hispanic women, a condition that often leads to diabetes.
Phase 3 results for alogliptin
Results from five pivotal phase 3 studies of alogliptin, which has been shown to be a highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4), were announced at the ADA 68th Scientific Sessions. Alogliptin administered once daily demonstrated statistically significant reductions in HbA1c versus placebo as a monotherapy and as an add-on therapy with the major classes of type 2 diabetes medications.
Having heart surgery? Watch your blood sugar, especially if you're overweight or older
Nearly half of all heart surgery patients may experience blood sugar levels high enough to require temporary insulin treatment after their operation, even though they've never had diabetes, according to a new study. And a significant minority of those patients might need to take medicines for days or even weeks after they leave the hospital, to help their blood sugar levels reach normal again, the researchers show.
IDF urges health care providers to address the relationship between type 2 diabetes and sleep apnea
The International Diabetes Federation warned today that recent research demonstrates that type 2 diabetes and obstructive sleep apnea are closely related, and that both disorders have significant implications on public health and on individuals.
© 2008 by Doctors Lounge